Lv31
258 积分 2023-05-15 加入
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
2小时前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
2小时前
已完结
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment
2天前
已完结
Current Biomarkers of IgA Nephropathy
11天前
已完结
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment
13天前
已完结
Antineutrophil Cytoplasmic Autoantibodies
2个月前
已关闭
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series
2个月前
已完结
Refractory Membranous Nephropathy With Anti-Rituximab Antibodies Treated Successfully With Obinutuzumab
3个月前
已关闭
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
3个月前
已完结
236-P: The HLA DRβ13 residue is associated with the development of human anti-chimeric antibody in some Crohn's patients treated with infliximab
3个月前
已完结
皖公网安备34019202002308
